Keywords
Last Name
Institution

CAROLYN L SMITH

TitleSenior Associate Dean
InstitutionBaylor College of Medicine
DepartmentGraduate School of Biomedical Sciences
AddressOne Baylor Plaza
Houston TX 77030
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Molecular & Cellular Biology
    DivisionMolecular & Cellular Biology

    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Urology
    DivisionUrology


    Collapse Additional Tools and Researcher Information 
    Collapse Faculty Mentor
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Nikolai BC, Lanz RB, York B, Dasgupta S, Mitsiades N, Creighton CJ, Tsimelzon A, Hilsenbeck SG, Lonard DM, Smith CL, O'Malley BW. HER2 Signaling Drives DNA Anabolism and Proliferation through SRC-3 Phosphorylation and E2F1-Regulated Genes. Cancer Res. 2016 Feb 1. PMID: 26833126.
      View in: PubMed
    2. Blackmore JK, Karmakar S, Gu G, Chaubal V, Wang L, Li W, Smith CL. The SMRT coregulator enhances growth of estrogen receptor-?-positive breast cancer cells by promotion of cell cycle progression and inhibition of apoptosis. Endocrinology. 2014 Sep; 155(9):3251-61. PMID: 24971610; PMCID: PMC4138560.
    3. Smith CL, Santen RJ, Komm B, Mirkin S. Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexes. Breast Cancer Res. 2014; 16(3):212. PMID: 25928299; PMCID: PMC4076629.
    4. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20; 507(7492):315-22. PMID: 24476821; PMCID: PMC3962515.
    5. Adikesavan AK, Karmakar S, Pardo P, Wang L, Liu S, Li W, Smith CL. Activation of p53 transcriptional activity by SMRT: a histone deacetylase 3-independent function of a transcriptional corepressor. Mol Cell Biol. 2014 Apr; 34(7):1246-61. PMID: 24449765; PMCID: PMC3993559.
    6. Smith CL, Santen RJ, Komm B and Mirkin S . Breast-related effects of selective estrogen receptor modulators and tissue selective estrogen complexes. Breast Cancer Research. 2014; 16:212-226.
    7. George SK, Tovar-Sepulveda V, Shen SS, Jian W, Zhang Y, Hilsenbeck SG, Lerner SP, Smith CL. Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen. Transl Oncol. 2013 Jun; 6(3):244-55. PMID: 23730403; PMCID: PMC3660792.
    8. Jiang XR, Wang P, Smith CL, Zhu BT. Synthesis of novel estrogen receptor antagonists using metal-catalyzed coupling reactions and characterization of their biological activity. J Med Chem. 2013 Apr 11; 56(7):2779-90. PMID: 23448346; PMCID: PMC3666588.
    9. Liu S, Han SJ, Smith CL. Cooperative activation of gene expression by agonists and antagonists mediated by estrogen receptor heteroligand dimer complexes. Mol Pharmacol. 2013 May; 83(5):1066-77. PMID: 23462505; PMCID: PMC3629828.
    10. Smith CL, Jarrett M, Bierer SB. Integrating clinical medicine into biomedical graduate education to promote translational research: strategies from two new PhD programs. Acad Med. 2013 Jan; 88(1):137-43. PMID: 23165264; PMCID: PMC3529996.
    11. Smith CL, Migliaccio I, Chaubal V, Wu MF, Pace MC, Hartmaier R, Jiang S, Edwards DP, Gutiérrez MC, Hilsenbeck SG, Oesterreich S. Elevated nuclear expression of the SMRT corepressor in breast cancer is associated with earlier tumor recurrence. Breast Cancer Res Treat. 2012 Nov; 136(1):253-65. PMID: 23015261; PMCID: PMC3511772.
    12. Hoffman KL, Lerner SP, Smith CL. Raloxifene inhibits growth of RT4 urothelial carcinoma cells via estrogen receptor-dependent induction of apoptosis and inhibition of proliferation. Horm Cancer. 2013 Feb; 4(1):24-35. PMID: 22965848; PMCID: PMC3541450.
    13. Hoffman KL, Foster EA, Smith CL. The terminal substituents of 7?, 6-hexanyl derivatives of estradiol determine their selective estrogen receptor modulator versus agonist activities. Steroids. 2012 Apr; 77(5):496-503. PMID: 22326682; PMCID: PMC3303951.
    14. Smith CL, Brown KA and Simpson ER . Regulation of estrogen receptor activity and aromatase expression: roles of selective estrogen receptor modulators and metabolic factors. Translational Endocrinology & Metabolism. 2012; 3:45-73.
    15. Karmakar S, Foster EA, Blackmore JK, Smith CL. Distinctive functions of p160 steroid receptor coactivators in proliferation of an estrogen-independent, tamoxifen-resistant breast cancer cell line. Endocr Relat Cancer. 2011 Feb; 18(1):113-27. PMID: 21059860; PMCID: PMC3014261.
    16. Bruning JB, Parent AA, Gil G, Zhao M, Nowak J, Pace MC, Smith CL, Afonine PV, Adams PD, Katzenellenbogen JA, Nettles KW. Coupling of receptor conformation and ligand orientation determine graded activity. Nat Chem Biol. 2010 Nov; 6(11):837-43. PMID: 20924370; PMCID: PMC2974172.
    17. Karmakar S, Gao T, Pace MC, Oesterreich S, Smith CL. Cooperative activation of cyclin D1 and progesterone receptor gene expression by the SRC-3 coactivator and SMRT corepressor. Mol Endocrinol. 2010 Jun; 24(6):1187-202. PMID: 20392877; PMCID: PMC2875800.
    18. Williams CC, Basu A, El-Gharbawy A, Carrier LM, Smith CL, Rowan BG. Identification of four novel phosphorylation sites in estrogen receptor alpha: impact on receptor-dependent gene expression and phosphorylation by protein kinase CK2. BMC Biochem. 2009; 10:36. PMID: 20043841; PMCID: PMC2811108.
    19. Karmakar S, Foster EA, Smith CL. Estradiol downregulation of the tumor suppressor gene BTG2 requires estrogen receptor-alpha and the REA corepressor. Int J Cancer. 2009 Apr 15; 124(8):1841-51. PMID: 19117054; PMCID: PMC2669741.
    20. Giamas G, Castellano L, Feng Q, Knippschild U, Jacob J, Thomas RS, Coombes RC, Smith CL, Jiao LR, Stebbing J. CK1delta modulates the transcriptional activity of ERalpha via AIB1 in an estrogen-dependent manner and regulates ERalpha-AIB1 interactions. Nucleic Acids Res. 2009 May; 37(9):3110-23. PMID: 19339517; PMCID: PMC2685087.
    21. Karmakar S, Foster EA, Smith CL. Unique roles of p160 coactivators for regulation of breast cancer cell proliferation and estrogen receptor-alpha transcriptional activity. Endocrinology. 2009 Apr; 150(4):1588-96. PMID: 19095746; PMCID: PMC2659266.
    22. Peterson TJ, Karmakar S, Pace MC, Gao T, Smith CL. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity. Mol Cell Biol. 2007 Sep; 27(17):5933-48. PMID: 17591692; PMCID: PMC1952168.
    23. Sonpavde G, Okuno N, Weiss H, Yu J, Shen SS, Younes M, Jian W, Lerner SP, Smith CL. Efficacy of selective estrogen receptor modulators in nude mice bearing human transitional cell carcinoma. Urology. 2007 Jun; 69(6):1221-6. PMID: 17572228.
      View in: PubMed
    24. Smith CL, He Q, Huang L, Foster E, Puschett JB. Marinobufagenin interferes with the function of the mineralocorticoid receptor. Biochem Biophys Res Commun. 2007 May 18; 356(4):930-4. PMID: 17399682; PMCID: PMC1865579.
    25. Agoulnik IU, Vaid A, Nakka M, Alvarado M, Bingman WE, Erdem H, Frolov A, Smith CL, Ayala GE, Ittmann MM, Weigel NL. Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer. Cancer Res. 2006 Nov 1; 66(21):10594-602. PMID: 17079484.
      View in: PubMed
    26. Raviscioni M, He Q, Salicru EM, Smith CL, Lichtarge O. Evolutionary identification of a subtype specific functional site in the ligand binding domain of steroid receptors. Proteins. 2006 Sep 1; 64(4):1046-57. PMID: 16835908.
      View in: PubMed
    27. Jaber BM, Gao T, Huang L, Karmakar S, Smith CL. The pure estrogen receptor antagonist ICI 182,780 promotes a novel interaction of estrogen receptor-alpha with the 3',5'-cyclic adenosine monophosphate response element-binding protein-binding protein/p300 coactivators. Mol Endocrinol. 2006 Nov; 20(11):2695-710. PMID: 16840538.
      View in: PubMed
    28. Shen SS, Smith CL, Hsieh JT, Yu J, Kim IY, Jian W, Sonpavde G, Ayala GE, Younes M, Lerner SP. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue. Cancer. 2006 Jun 15; 106(12):2610-6. PMID: 16700038.
      View in: PubMed
    29. García-Becerra R, Borja-Cacho E, Cooney AJ, Smith CL, Lemus AE, Pérez-Palacios G, Larrea F. Synthetic 19-nortestosterone derivatives as estrogen receptor alpha subtype-selective ligands induce similar receptor conformational changes and steroid receptor coactivator recruitment than natural estrogens. J Steroid Biochem Mol Biol. 2006 May; 99(2-3):108-14. PMID: 16616843.
      View in: PubMed
    30. Zheng FF, Wu RC, Smith CL, O'Malley BW. Rapid estrogen-induced phosphorylation of the SRC-3 coactivator occurs in an extranuclear complex containing estrogen receptor. Mol Cell Biol. 2005 Sep; 25(18):8273-84. PMID: 16135815; PMCID: PMC1234335.
    31. Agoulnik IU, Vaid A, Bingman WE, Erdeme H, Frolov A, Smith CL, Ayala G, Ittmann MM, Weigel NL. Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression. Cancer Res. 2005 Sep 1; 65(17):7959-67. PMID: 16140968.
      View in: PubMed
    32. Wu RC, Smith CL, O'Malley BW. Transcriptional regulation by steroid receptor coactivator phosphorylation. Endocr Rev. 2005 May; 26(3):393-9. PMID: 15814849.
      View in: PubMed
    33. Labhart P, Karmakar S, Salicru EM, Egan BS, Alexiadis V, O'Malley BW, Smith CL. Identification of target genes in breast cancer cells directly regulated by the SRC-3/AIB1 coactivator. Proc Natl Acad Sci U S A. 2005 Feb 1; 102(5):1339-44. PMID: 15677324; PMCID: PMC547886.
    34. Smith CL. Estrogen receptor targeted therapies: mechanisms of action and future developments. Menopause Management. 2005; 14(Suppl 1):40-43.
    35. Coleman KM, Lam V, Jaber BM, Lanz RB, Smith CL. SRA coactivation of estrogen receptor-alpha is phosphorylation-independent, and enhances 4-hydroxytamoxifen agonist activity. Biochem Biophys Res Commun. 2004 Oct 8; 323(1):332-8. PMID: 15351741.
      View in: PubMed
    36. Lee CY, Liu X, Smith CL, Zhang X, Hsu HC, Wang DY, Luo ZP. The combined regulation of estrogen and cyclic tension on fibroblast biosynthesis derived from anterior cruciate ligament. Matrix Biol. 2004 Aug; 23(5):323-9. PMID: 15464364.
      View in: PubMed
    37. Narayanan R, Allen MR, Gaddy D, Bloomfield SA, Smith CL, Weigel NL. Differential skeletal responses of hindlimb unloaded rats on a vitamin D-deficient diet to 1,25-dihydroxyvitamin D3 and its analog, seocalcitol (EB1089). Bone. 2004 Jul; 35(1):134-43. PMID: 15207749.
      View in: PubMed
    38. Lee CY, Smith CL, Zhang X, Hsu HC, Wang DY, Luo ZP. Tensile forces attenuate estrogen-stimulated collagen synthesis in the ACL. Biochem Biophys Res Commun. 2004 May 14; 317(4):1221-5. PMID: 15094400.
      View in: PubMed
    39. Jaber BM, Mukopadhyay R, Smith CL. Estrogen receptor-alpha interaction with the CREB binding protein coactivator is regulated by the cellular environment. J Mol Endocrinol. 2004 Feb; 32(1):307-23. PMID: 14766010.
      View in: PubMed
    40. Smith CL, O'Malley BW. Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev. 2004 Feb; 25(1):45-71. PMID: 14769827.
      View in: PubMed
    41. Cavarretta IT, Martini L, Motta M, Smith CL, Melcangi RC. SRC-1 is involved in the control of the gene expression of myelin protein Po. J Mol Neurosci. 2004; 24(2):217-26. PMID: 15456935.
      View in: PubMed
    42. Dutertre M, Smith CL. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains. Mol Endocrinol. 2003 Jul; 17(7):1296-314. PMID: 12714702.
      View in: PubMed
    43. Coleman KM, Dutertre M, El-Gharbawy A, Rowan BG, Weigel NL, Smith CL. Mechanistic differences in the activation of estrogen receptor-alpha (ER alpha)- and ER beta-dependent gene expression by cAMP signaling pathway(s). J Biol Chem. 2003 Apr 11; 278(15):12834-45. PMID: 12566449.
      View in: PubMed
    44. Narayanan R, Smith CL, Weigel NL. Vector-averaged gravity-induced changes in cell signaling and vitamin D receptor activity in MG-63 cells are reversed by a 1,25-(OH)2D3 analog, EB1089. Bone. 2002 Sep; 31(3):381-8. PMID: 12231410.
      View in: PubMed
    45. Cavarretta IT, Mukopadhyay R, Lonard DM, Cowsert LM, Bennett CF, O'Malley BW, Smith CL. Reduction of coactivator expression by antisense oligodeoxynucleotides inhibits ERalpha transcriptional activity and MCF-7 proliferation. Mol Endocrinol. 2002 Feb; 16(2):253-70. PMID: 11818499.
      View in: PubMed
    46. Lonard DM, Smith CL. Molecular perspectives on selective estrogen receptor modulators (SERMs): progress in understanding their tissue-specific agonist and antagonist actions. Steroids. 2002 Jan; 67(1):15-24. PMID: 11728517.
      View in: PubMed
    47. Smith CL, DeVera DG, Lamb DJ, Nawaz Z, Jiang YH, Beaudet AL, O'Malley BW. Genetic ablation of the steroid receptor coactivator-ubiquitin ligase, E6-AP, results in tissue-selective steroid hormone resistance and defects in reproduction. Mol Cell Biol. 2002 Jan; 22(2):525-35. PMID: 11756548; PMCID: PMC139730.
    48. Walters MR, Dutertre M, Smith CL. SKF-82958 is a subtype-selective estrogen receptor-alpha (ERalpha ) agonist that induces functional interactions between ERalpha and AP-1. J Biol Chem. 2002 Jan 18; 277(3):1669-79. PMID: 11700319.
      View in: PubMed
    49. Coleman KM, Smith CL. Intracellular signaling pathways: nongenomic actions of estrogens and ligand-independent activation of estrogen receptors. Front Biosci. 2001 Oct 1; 6:D1379-91. PMID: 11578956.
      View in: PubMed
    50. Larrea F, García-Becerra R, Lemus AE, García GA, Pérez-Palacios G, Jackson KJ, Coleman KM, Dace R, Smith CL, Cooney AJ. A-ring reduced metabolites of 19-nor synthetic progestins as subtype selective agonists for ER alpha. Endocrinology. 2001 Sep; 142(9):3791-9. PMID: 11517155.
      View in: PubMed
    51. Marino M, Distefano E, Trentalance A, Smith CL. Estradiol-induced IP(3) mediates the estrogen receptor activity expressed in human cells. Mol Cell Endocrinol. 2001 Aug 20; 182(1):19-26. PMID: 11500235.
      View in: PubMed
    52. Stenoien DL, Nye AC, Mancini MG, Patel K, Dutertre M, O'Malley BW, Smith CL, Belmont AS, Mancini MA. Ligand-mediated assembly and real-time cellular dynamics of estrogen receptor alpha-coactivator complexes in living cells. Mol Cell Biol. 2001 Jul; 21(13):4404-12. PMID: 11390668; PMCID: PMC87100.
    53. Stenoien DL, Patel K, Mancini MG, Dutertre M, Smith CL, O'Malley BW, Mancini MA. FRAP reveals that mobility of oestrogen receptor-alpha is ligand- and proteasome-dependent. Nat Cell Biol. 2001 Jan; 3(1):15-23. PMID: 11146621.
      View in: PubMed
    54. Dutertre M, Smith CL. Molecular mechanisms of selective estrogen receptor modulator (SERM) action. J Pharmacol Exp Ther. 2000 Nov; 295(2):431-7. PMID: 11046073.
      View in: PubMed
    55. Lonard DM, Nawaz Z, Smith CL, O'Malley BW. The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation. Mol Cell. 2000 Jun; 5(6):939-48. PMID: 10911988.
      View in: PubMed
    56. Stenoien DL, Mancini MG, Patel K, Allegretto EA, Smith CL, Mancini MA. Subnuclear trafficking of estrogen receptor-alpha and steroid receptor coactivator-1. Mol Endocrinol. 2000 Apr; 14(4):518-34. PMID: 10770489.
      View in: PubMed
    57. Smith CL, O'Malley BW. Evolving concepts of selective estrogen receptor action: from basic science to clinical applications. Trends Endocrinol Metab. 1999 Oct; 10(8):299-300. PMID: 10481159.
      View in: PubMed
    58. Nawaz Z, Lonard DM, Dennis AP, Smith CL, O'Malley BW. Proteasome-dependent degradation of the human estrogen receptor. Proc Natl Acad Sci U S A. 1999 Mar 2; 96(5):1858-62. PMID: 10051559; PMCID: PMC26701.
    59. Nawaz Z, Lonard DM, Smith CL, Lev-Lehman E, Tsai SY, Tsai MJ, O'Malley BW. The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol Cell Biol. 1999 Feb; 19(2):1182-9. PMID: 9891052; PMCID: PMC116047.
    60. Smith CL. Multiple intracellular signaling pathways cross-talk with the estrogen receptor. J Med Food. 1999; 2(3-4):177. PMID: 19281373.
      View in: PubMed
    61. Smith CL, Kreutner W. In vitro glucocorticoid receptor binding and transcriptional activation by topically active glucocorticoids. Arzneimittelforschung. 1998 Sep; 48(9):956-60. PMID: 9793625.
      View in: PubMed
    62. Stenoien D, Sharp ZD, Smith CL, Mancini MA. Functional subnuclear partitioning of transcription factors. J Cell Biochem. 1998 Aug 1; 70(2):213-21. PMID: 9671227.
      View in: PubMed
    63. Smith CL. Cross-talk between peptide growth factor and estrogen receptor signaling pathways. Biol Reprod. 1998 Mar; 58(3):627-32. PMID: 9510949.
      View in: PubMed
    64. Smith CL, Nawaz Z, O'Malley BW. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol Endocrinol. 1997 Jun; 11(6):657-66. PMID: 9171229.
      View in: PubMed
    65. Smith CL, Oñate SA, Tsai MJ, O'Malley BW. CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. Proc Natl Acad Sci U S A. 1996 Aug 20; 93(17):8884-8. PMID: 8799122; PMCID: PMC38563.
    66. Apostolakis EM, Garai J, Fox C, Smith CL, Watson SJ, Clark JH, O'Malley BW. Dopaminergic regulation of progesterone receptors: brain D5 dopamine receptors mediate induction of lordosis by D1-like agonists in rats. J Neurosci. 1996 Aug 15; 16(16):4823-34. PMID: 8756415.
      View in: PubMed
    67. Smith CL, Conneely OM, O'Malley BW. Oestrogen receptor activation in the absence of ligand. Biochem Soc Trans. 1995 Nov; 23(4):935-9. PMID: 8654870.
      View in: PubMed
    68. O'Malley BW, Schrader WT, Mani S, Smith C, Weigel NL, Conneely OM, Clark JH. An alternative ligand-independent pathway for activation of steroid receptors. Recent Prog Horm Res. 1995; 50:333-47. PMID: 7740165.
      View in: PubMed
    69. Hammond GL, Bocchinfuso WP, Orava M, Smith CL, van den Ende A, van Enk A. Serum distribution of two contraceptive progestins: 3-ketodesogestrel and gestodene. Contraception. 1994 Oct; 50(4):301-18. PMID: 7813219.
      View in: PubMed
    70. Hammond GL, Smith CL, Lähteenmäki P, Grolla A, Warmels-Rodenhiser S, Hodgert H, Murai JT, Siiteri PK. Squirrel monkey corticosteroid-binding globulin: primary structure and comparison with the human protein. Endocrinology. 1994 Feb; 134(2):891-8. PMID: 8299584.
      View in: PubMed
    71. Smith CL, Conneely OM, O'Malley BW. Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone. Proc Natl Acad Sci U S A. 1993 Jul 1; 90(13):6120-4. PMID: 8327492; PMCID: PMC46879.
    72. Scrocchi LA, Orava M, Smith CL, Han VK, Hammond GL. Spatial and temporal distribution of corticosteroid-binding globulin and its messenger ribonucleic acid in embryonic and fetal mice. Endocrinology. 1993 Feb; 132(2):903-9. PMID: 7916682.
      View in: PubMed
    73. Yang K, Smith CL, Dales D, Hammond GL, Challis JR. Cloning of an ovine 11 beta-hydroxysteroid dehydrogenase complementary deoxyribonucleic acid: tissue and temporal distribution of its messenger ribonucleic acid during fetal and neonatal development. Endocrinology. 1992 Nov; 131(5):2120-6. PMID: 1425412.
      View in: PubMed
    74. Smith CL, Power SG, Hammond GL. A Leu----His substitution at residue 93 in human corticosteroid binding globulin results in reduced affinity for cortisol. J Steroid Biochem Mol Biol. 1992 Aug; 42(7):671-6. PMID: 1504007.
      View in: PubMed
    75. Smith CL, Hammond GL. Hormonal regulation of corticosteroid-binding globulin biosynthesis in the male rat. Endocrinology. 1992 Apr; 130(4):2245-51. PMID: 1547738.
      View in: PubMed
    76. Smith CL, Hammond GL. An amino acid substitution in biobreeding rat corticosteroid binding globulin results in reduced steroid binding affinity. J Biol Chem. 1991 Oct 5; 266(28):18555-9. PMID: 1917978.
      View in: PubMed
    77. Smith CL, Hammond GL. Ontogeny of corticosteroid-binding globulin biosynthesis in the rat. Endocrinology. 1991 Feb; 128(2):983-8. PMID: 1989877.
      View in: PubMed
    78. Hammond GL, Smith CL, Underhill DA. Molecular studies of corticosteroid binding globulin structure, biosynthesis and function. J Steroid Biochem Mol Biol. 1991; 40(4-6):755-62. PMID: 1958574.
      View in: PubMed
    79. Hammond GL, Smith CL, Underhill CM, Nguyen VT. Interaction between corticosteroid binding globulin and activated leukocytes in vitro. Biochem Biophys Res Commun. 1990 Oct 15; 172(1):172-7. PMID: 2222468.
      View in: PubMed
    80. Seralini GE, Smith CL, Hammond GL. Rabbit corticosteroid-binding globulin: primary structure and biosynthesis during pregnancy. Mol Endocrinol. 1990 Aug; 4(8):1166-72. PMID: 2293023.
      View in: PubMed
    81. Hammond GL, Smith CL, Paterson NA, Sibbald WJ. A role for corticosteroid-binding globulin in delivery of cortisol to activated neutrophils. J Clin Endocrinol Metab. 1990 Jul; 71(1):34-9. PMID: 2370299.
      View in: PubMed
    82. Hammond GL, Underhill DA, Rykse HM, Smith CL. The human sex hormone-binding globulin gene contains exons for androgen-binding protein and two other testicular messenger RNAs. Mol Endocrinol. 1989 Nov; 3(11):1869-76. PMID: 2608061.
      View in: PubMed
    83. Seralini GE, Underhill CM, Smith CL, Nguyen VT, Hammond GL. Biological half-life and transfer of maternal corticosteroid-binding globulin to amniotic fluid in the rabbit. Endocrinology. 1989 Sep; 125(3):1321-5. PMID: 2759028.
      View in: PubMed
    84. Smith CL, Hammond GL. Rat corticosteroid binding globulin: primary structure and messenger ribonucleic acid levels in the liver under different physiological conditions. Mol Endocrinol. 1989 Feb; 3(2):420-6. PMID: 2710140.
      View in: PubMed
    85. Kikukawa, S., Smith, C.L. and Tobe, S.S. . Morphogenetic and gonadotrophic effects of a juvenile hormone analogue ((7s)-hydroprene) in last instar female larvae of Diploptera punctata. Physiological Entomology. 1989; 14:165-172.
    86. Smith CL, Hammond GL. The amino acid sequence of rat CBG deduced from a cDNA, and identification of CBG mRNA in the liver under different physiological states. Steroids. 1988 Oct; 52(4):331-2. PMID: 3250013.
      View in: PubMed
    87. Bardin CW, Gunsalus GL, Musto NA, Cheng CY, Reventos J, Smith C, Underhill DA, Hammond G. Corticosteroid binding globulin, testosterone-estradiol binding globulin, and androgen binding protein belong to protein families distinct from steroid receptors. J Steroid Biochem. 1988; 30(1-6):131-9. PMID: 3386241.
      View in: PubMed
    88. Hammond GL, Smith CL, Goping IS, Underhill DA, Harley MJ, Reventos J, Musto NA, Gunsalus GL, Bardin CW. Primary structure of human corticosteroid binding globulin, deduced from hepatic and pulmonary cDNAs, exhibits homology with serine protease inhibitors. Proc Natl Acad Sci U S A. 1987 Aug; 84(15):5153-7. PMID: 3299377; PMCID: PMC298812.
    89. Hammond GL, Underhill DA, Smith CL, Goping IS, Harley MJ, Musto NA, Cheng CY, Bardin CW. The cDNA-deduced primary structure of human sex hormone-binding globulin and location of its steroid-binding domain. FEBS Lett. 1987 May 4; 215(1):100-4. PMID: 3569533.
      View in: PubMed
    90. Younoszai MK, Smith C, Finch MH. Comparison of in vitro jejunal uptake of L-valine and L-lysine in the rat during maturation. J Pediatr Gastroenterol Nutr. 1985 Dec; 4(6):992-7. PMID: 3934359.
      View in: PubMed
    SMITH's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _